Sign inGet started

TURKEL CATHERINE C.

Insider CIK 1705278 · LEXX Director · NVUS President

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
LEXX Lexaria Bioscience Corp. P Buy2024-08-122024-08-131,600$3.13 $5.0K3,100SEC↗
LEXX Lexaria Bioscience Corp. A Award deriv2024-07-262024-07-3012,000— $027,000SEC↗
LEXX Lexaria Bioscience Corp. A Award deriv2024-04-262024-05-105,000— $015,000SEC↗
LEXX Lexaria Bioscience Corp. A Award deriv2023-07-252023-07-255,000— $010,000SEC↗
LEXX Lexaria Bioscience Corp. P Buy2023-02-092023-02-271,500$2.84 $4.3K1,500SEC↗
LEXX Lexaria Bioscience Corp. A Award deriv2022-10-122022-10-131,600— $05,000SEC↗
LEXX Lexaria Bioscience Corp. A Award deriv2022-09-022022-09-063,400— $03,400SEC↗
NVUS Novus Therapeutics, Inc. A Award deriv2020-03-192020-03-20100,000— $0100,000SEC↗
NVUS Novus Therapeutics, Inc. A Award deriv2019-09-262019-09-3075,000— $075,000SEC↗
NVUS Novus Therapeutics, Inc. S Sale2019-05-212019-05-221,914$1.91 $3.7K88,662SEC↗
NVUS Novus Therapeutics, Inc. S Sale2019-05-202019-05-227,623$1.96 $14.9K90,576SEC↗
NVUS Novus Therapeutics, Inc. A Award deriv2019-03-142019-03-1850,000— $050,000SEC↗
NVUS Novus Therapeutics, Inc. A Award2019-03-142019-03-1820,000— $098,199SEC↗
NVUS Novus Therapeutics, Inc. P Buy2018-09-122018-09-1316,632$5.02 $83.5K78,199SEC↗
NVUS Novus Therapeutics, Inc. P Buy2018-09-112018-09-1317,048$4.56 $77.7K61,567SEC↗
NVUS Novus Therapeutics, Inc. P Buy2018-09-052018-09-07805$3.97 $3.2K805SEC↗
NVUS Novus Therapeutics, Inc. A Award deriv2018-03-132018-03-1524,000— $024,000SEC↗
NVUS Novus Therapeutics, Inc. A Award2018-03-132018-03-1520,000— $044,519SEC↗
NVUS Novus Therapeutics, Inc. A Award deriv2017-11-062017-11-0650,000— $050,000SEC↗
NVUS Novus Therapeutics, Inc. A Award deriv2017-05-242017-05-2652,500— $052,500SEC↗
NVUS Novus Therapeutics, Inc. P Buy2017-05-102017-05-1111,111$9.99 $111.0K24,519SEC↗